What is David Biegger’s Freshpet (FRPT) share ownership after this grant?

After receiving the 1,589-share restricted stock grant, David Biegger directly holds 7,488 shares of Freshpet common stock. This figure reflects his position immediately following the reported award and helps show the scale of the grant relative to his holdings.

Freshpet director granted 1,589 restricted shares

Biegger David reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/12/2026 - 07:54 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Biegger David reported acquisition or exercise transactions in this Form 4 filing.

Freshpet, Inc. director David Biegger received an award of 1,589 shares of restricted common stock, with no cash paid per share. The grant was made under the company’s 2024 Equity Incentive Plan and will vest on March 15, 2027, if he continues serving on the board. Following this award, he directly holds 7,488 common shares.

Insider Trade Summary

Grant/Award: 1,589 shares

Grant/Award 1 txn

Insider Biegger David

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,589	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,488 shares (Direct)

Footnotes (1)

F1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Freshpet (FRPT) director David Biegger report in this Form 4?

Director David Biegger reported receiving 1,589 shares of restricted Freshpet common stock as a grant. The award was issued at no cash cost per share and increases his direct holdings to 7,488 shares after the transaction.

How many Freshpet (FRPT) shares did David Biegger acquire and at what price?

David Biegger acquired 1,589 shares of Freshpet common stock through a grant at a reported price of $0.00 per share. This indicates a compensation-related equity award rather than an open-market purchase of shares.

When do David Biegger’s new Freshpet (FRPT) restricted shares vest?

The 1,589 restricted Freshpet common shares granted to David Biegger vest on March 15, 2027. Vesting is conditioned on his continued service on Freshpet’s Board of Directors through that date under the company’s 2024 Equity Incentive Plan.

Is David Biegger’s Freshpet (FRPT) Form 4 transaction a market purchase or sale?

The Form 4 shows a grant or award acquisition, not a market trade. The code “A” and price of $0.00 per share indicate compensation-related restricted stock, rather than an open-market buy or sell transaction in Freshpet shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Biegger David

(Last)

(First)

(Middle)

C/O FRESHPET, INC.

1450 US-206

(Street)

BEDMINSTER

07921

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/10/2026		A		1,589⁽¹⁾	A	$0	7,488	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

	/s/ Lisa A. Alexander, as Attorney-in-Fact for the Reporting Person	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR